Susan Greenfield, Baroness Greenfield

Susan Greenfield, Baroness Greenfield, born on October first, nineteen fifty, is a distinguished English scientist and writer, renowned for her contributions to the fields of biology and neuroscience. As a member of the House of Lords since two thousand one, she has been an influential voice in discussions surrounding science and technology.

Her research primarily focuses on the treatment of neurodegenerative diseases such as Parkinson's and Alzheimer's. Greenfield's interest extends to the neuroscience of consciousness and the effects of technology on the human brain, making her a pivotal figure in contemporary scientific discourse.

In addition to her research, Greenfield has held prestigious academic positions, including serving as a senior research fellow at Lincoln College, Oxford, and as a professor of Synaptic Pharmacology. Her leadership experience includes her role as chancellor of Heriot-Watt University in Edinburgh from two thousand five to two thousand thirteen, and as director of the Royal Institution of Great Britain from nineteen ninety-eight to two thousand ten.

In September two thousand thirteen, she co-founded Neuro-bio Ltd, a biotech company where she serves as chief executive officer, further demonstrating her commitment to advancing scientific innovation.